Table 2 Blood Transfusion and Chelation Therapy Data of the Study Population
Transfusion and Chelation Variables | Data |
|---|---|
Disease duration (years) | |
 - Mean (SD) | 8.1 (±4.9) |
 - Range | 1–17 |
Age at 1st blood transfusion (years) | |
 - Mean (SD) | 1.5 (±1.5) |
 - Range | 0.5–9 |
Blood transfusion duration (years) | |
 - Mean (SD) | 8.04 (±4.94) |
 - Range | 1–17 |
RBC Transfusion Index (ml/kg/year) | |
 - Mean (SD) | 183.14 (±48.5) |
 - Range | 30–360 |
Transfusion frequency (times/year) | |
 - Mean (SD) | 12 (±6) |
 - Range | 4–20 |
Type of chelation No (%) | |
 - Deferasirox | 204 (42.8) |
 - Deferiprone | 93 (19.5) |
 - Desferoxamin | 58 (12.2) |
 - Combination) Deferasirox/Desferoxamine( | 72 (15.1) |
 - None | 50 (10.5) |
Compliance No (%) | |
 - Compliant | 149 (35) |
 -Noncompliant | 278 (65) |
Chelation duration (years) | |
 - Mean (SD) | 7.2 (±4.6) |
 - Range | 0.5–17 |